CONDITIONAL KNOCKOUT OF P53 IN MESENCHYMAL CELLS OF MICE RESULTS IN OSTEOSARCOMAS

Post on 03-Jan-2016

17 views 0 download

Tags:

description

CONDITIONAL KNOCKOUT OF P53 IN MESENCHYMAL CELLS OF MICE RESULTS IN OSTEOSARCOMAS. PATRICK P. LIN, FENGHUA JIN, GUILLERMINO LOZANO November 13, 2004 Montreal, Canada. Introduction. P53. Tumor suppressor gene Most commonly mutated tumor suppressor Approximately 50% of all cancers - PowerPoint PPT Presentation

Transcript of CONDITIONAL KNOCKOUT OF P53 IN MESENCHYMAL CELLS OF MICE RESULTS IN OSTEOSARCOMAS

CONDITIONAL KNOCKOUT OF P53 IN MESENCHYMAL CELLS OF MICE

RESULTS IN OSTEOSARCOMAS

PATRICK P. LIN, FENGHUA JIN, GUILLERMINO LOZANO

November 13, 2004Montreal, Canada

Introduction

P53

• Tumor suppressor gene– Most commonly mutated tumor suppressor – Approximately 50% of all cancers

• Guardian of the genome– Activated in response to DNA damage– Cell cycle arrest– Apoptosis

Li-Fraumeni SyndromeGerm-Line P53 Mutation

Hisada, JNCI 90:606, 1998

P53 Knockout Mice

• Developed in early 1990s

• Mice exhibit a wide spectrum of tumors

• Problem – Homozygous knockout die of lymphomas rapidly

• Within 6 months

• Relatively few sarcomas

– Heterozygous knockout produces sarcomas slowly• Usually about 18 months

P53 Deficient Mice

Heterozygousknockout

Homozygousknockout

Jacks et al, Current Biology 4:1, 1994Donehower, Current Biology 7:296, 1996

Rb

• Another important tumor suppressor gene

• Involved in cell cycle control

Hereditary RetinoblastomaGermline Mutation of Rb

• Osteosarcoma 2nd most common malignancy

• Rb - mutations found in sporadic osteosarcomas also

Rb Knockout Mice

• Homozygous mice are embryonic lethal

• Heterozygous mice only develop pituitary tumors– No osteosarcomas or other sarcomas

Goal of This Study

• Develop genetic mouse model of sarcomas– Effect of specific mutations on tumor phenotype

• Tumor suppressor genes

Strategy

• Conditional knockout of tumor suppressor genes – Early knockout

• Less differentiated cells more likely to give rise to tumors

– Only in mesenchymal tissue • Bone, cartilage, muscle, connective tissue

Cre-Lox Recombination

• Cre recombinase– Transgenic mouse expresses Cre under the control of a specific

promoter

• LoxP sites– Short 34 bp sequence recognized by Cre

– Introduce into mouse genome around targeted gene

creloxP loxP loxP

gene

Published WorkRb/P53 Conditional Knockout in Brain

• GFAP-Cre x P53lox/lox Rblox/lox

– 100% medulloblastomas • within 4 months

• GFAP (glial fibrillary acidic protein) – expressed only in brain

Marino et al, Genes & Dev 14:994, 2000

Prx1

• Paired-related homeobox gene– Previously called Mhox– Regulates embryonic development

• Prx1 Knockout mice– Craniofacial defects– Limb shortening– Spina bifida

Prx1 Expression in Embryoes

• Primarily in Limbs & Cranial Mesenchyme

Martin, Genesis 26:225, 2000

Prx1 Expression in Embryonic Tissue

• Not in epithelium – (e & ep, panels B,D)

• Only in mesoderm– Condensing mesenchyme

of limb bud (cm, panel C)

– Mesenchyme (m, panel D)

– Periosteum (p, panels E,F)

– Maxillary process (mp, panels A,B)

Martin, Genesis 26:225, 2000

Prx1-Cre Transgenic Mouse

• Utilizes 2.4 kb fragment– 5’ genomic flanking region of Prx1 gene– contains 530 bp core fragment of Prx1 promoter

Logan, Genesis 33:77, 2002

Prx1-Cre Expression

• Prx1-Cre is expressed primarily in limbs– Cross to R26R (Rosa26 lacZ reporter)

P53lox and Rblox Mice

loxlox

1 2 3 4 5 6 7 8 9 10 11

P53lox

Rblox

Exon 19

loxlox

Marino, Genes & Dev 14:994, 2000

Results

Tumor Cohorts

Cohort #Mice Age (wks)

Tumors

Prx1-Cre+/- Rblox/lox 13 44-98 1

Prx1-Cre+/- Rblox/NULL 8 44-98 0

Prx1-Cre+/- P53lox/WT 23 33-96 4

Prx1-Cre+/- P53lox/lox 25 42-68 18

Prx1Cre – mediated knockout of p53

Time (wks)

120100806040200

Ove

rall

Su

rviv

al

1.0

.8

.6

.4

.2

0.0

p53-lox/lox

p53-lox/w t

p=0.008

Cause of DeathPrx1cre P53 lox/lox

Osteosarcoma

Soft tissue sarcoma

Non-tumor

Lymphoma

Osteosarcomamouse 1296 age 39 wks

femur

Location of Osteosarcoma Proximal Femur Predominant Site

Mouse 1304age 40 wks

scapula

Genotype of Tumor

• PCR verifies loss of floxed P53 gene in tumor

Tail

Tumo

rNeg

contr

ol

Osteoblastic Osteosarcoma

Osteosarcoma Metastasis Prx1cre P53 lox/lox

• Lung: 2 of 12 (17%) mice– Visible on Xray or necropsy

– Microscopic mets not easily detectable

– Primary tumor grows extremely fast (days)

• Bone: 4 of 12 tumors• Spleen: 1 of 12 tumors

Metastatic vs. Multifocal Disease?

• 4 of 12 (33%) mice • Osteoblastic tumors in

multiple bones• Multifocal disease vs. mets?

– 1 mouse had both lung and bone mets

Soft Tissue Sarcoma

• Poorly differentiated, unclassified soft tissue sarcoma

• No osteoid

• No involvement of bone

Lymphoma of Bone

• Rarely seen• Arose in bone• Thymus not involved

Rb Conditional KnockoutRblox/lox and Rblox/null

• No developmental abnormalities– Limbs normal

– Mice fertile

• No sarcomas– Most die of old age

– 1 tumor (thyroid)

• Rb knockout does not initiate sarcoma formation in mice! Time (wks)

100806040200

Ove

rall

Su

rviv

al

1.0

.8

.6

.4

.2

0.0

Rb lox/null

Rb lox/lox

Rb Knockout Accelerates Sarcoma Formation

• Simultaneous conditional knockout of p53 and Rb

• p < 0.0001

• Preliminary data

– Utilizes col2A1cre mouse to achieve double conditional knockout

Weeks

80706050403020100

Su

rviv

al

1.0

.8

.6

.4

.2

0.0

col2A1crep53lox/lox Rblox/lox

prx1crep53lox/lox

Weeks

80706050403020100

Su

rviv

al

1.0

.8

.6

.4

.2

0.0

col2A1crep53lox/lox Rblox/lox

prx1crep53lox/lox

Discussion

Preliminary Study

• Establishes framework for future studies

• Larger numbers of mice needed to corroborate initial findings here

Mice Tend to Make Osteosarcomas

• Distribution of tumors is not random– Histology - osteosarcomas– Location - femur – Not predicted

• Prx1-cre knock outs p53 in the limb bud• All mesenchymal tissues in limb should have equal chance of tumor

formation

• There must be strong genetic & developmental influences that favors osteosarcoma in femur

P53 Conditional Knockout

• Good strategy to create sarcomas– Eliminate nearly all other tumors

• Occasional lymphoma of bone occurs

– Confirms hypothesis that mice bearing homozygous deletion of p53 will almost always develop sarcomas

• P53 mutation is an initiating event for sarcomas– Represents one important pathway for sarcoma formation

– This is generally not believed to be true for carcinomas

Rb Conditional Knockout

• No developmental defects (surprisingly)– Note global Rb knockout is lethal in embryoes

• Poor initiator of sarcoma formation in mice– No tumors with Rb knockout alone

• Accelerates sarcoma formation– Double knockout of p53 & Rb produces sarcomas

more rapidly

Conclusions

• Conditional knockout of p53 produces sarcomas – Majority are osteoblastic osteosarcomas of femur– Poorly differentiated soft tissue sarcomas also form

• Conditional knockout of Rb accelerates sarcoma formation– Does not initiate sarcoma formation in mice

Acknowledgements

• Orthopaedic Research & Education Foundation Grant (02-026)

• Anton Berns• John Parant• Jim Martin• Carolyn Van Pelt• Richard Behringer• Victor Olnichikov

Thank You